In BC cells, estrogen promotes tumor progression by inhibiting apoptosis through upregulated anti-apoptotic Bcl-2 and Bcl-X L (Musgrove and Sutherland, 2009) and activation of MAPK and PI3K/Akt pathways (Gompel et al., 2000). The gene discussed is BCL2; the disease is breast cancer.